Overbrook Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2M Buy
29,366
+1,479
+5% +$1.51M 5.31% 5
2026
Q1
$25.6M Sell
27,887
-402
-1% -$408K 4.84% 8
2025
Q4
$30.4M Sell
28,289
-13,597
-32% -$13M 5.25% 7
2025
Q3
$32M Buy
41,886
+14,518
+53% +$10.8M 5.75% 7
2025
Q2
$21.3M Buy
27,368
+17,918
+190% +$13.9M 3.98% 10
2025
Q1
$7.8M Sell
9,450
-33
-0.3% -$27.5K 1.83% 21
2024
Q4
$7.32M Buy
+9,483
New +$7.85M 1.58% 25

Other funds holding LLY

Overbrook Management Corp's LLY Position: Q2 2026 in Review

Overbrook Management Corp increased its Eli Lilly (LLY) stake by 5.3% in Q2 2026, buying an estimated $1.51M and bringing the position to 29,366 shares worth $35.2M. The position accounts for 5.31% of the portfolio, ranked #5.

Overbrook Management Corp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Overbrook Management Corp held 29,366 shares of Eli Lilly worth $35.2M as of Q2 2026.
  • Overbrook Management Corp bought 1,479 Eli Lilly shares in Q2 2026, an estimated $1.51M.
  • Eli Lilly made up 5.31% of Overbrook Management Corp's portfolio in Q2 2026, its #5 holding.
  • Overbrook Management Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Overbrook Management Corp's 13F filing for Q2 2026, filed 30 Jul 2026.